Corporate Information Corporate Data

Mitsubishi Chemical Holdings Corporation (As of March 31, 2016) Value Creation Process

Address of the head office 1-1 Marunouchi 1-chome, Chiyoda-ku, Tokyo 100-8251 Establishment October 3, 2005 Paid-in capital ¥50.0 billion Net sales (consolidated) ¥3,823.0 billion (fiscal 2015) Number of employees (consolidated) 68,988

Organizational Structure Strategy Holding company Function-sharing companies Formulation of Group strategies, optimal allocation of management resources, supervision of business management and others Investigation into future societal issues and research for proving solutions to those issues 1 100% MCHC* The KAITEKI Institute

Regional control companies Overseas administrative representatives in North America, Europe and China 100% Mitsubishi Chemical Holdings America Results 100% Mitsubishi Chemical Holdings (Beijing)

100% Mitsubishi Chemical Holdings Europe

Common function companies General affairs, accounting, financial affairs and auditing 100% Mitsubishi Chemical Holdings Corporate Staff

Advance of common platform technologies in R&D

100% Governance MCHC R&D Synergy Center

Operating companies Business operations in the three domains of Performance Products, Industrial Materials and Health Care

100% 56.3% 100% 100% 100% 50.5%*2

MCC*3 MTPC*1 MPI*3 MRC*3 LSII TNSC*1

Paid-in capital Paid-in capital Paid-in capital Paid-in capital Paid-in capital Paid-in capital ¥50.0 billion ¥50.0 billion ¥21,503 million ¥53,229 million ¥3.0 billion ¥37,344 million

Net sales (consolidated) Net sales (consolidated) Net sales (consolidated) Net sales (consolidated) Net sales (consolidated) Net sales (consolidated) Financial Section ¥1,745.9 billion ¥431.7 billion ¥480.8 billion ¥548.4 billion ¥136.0 billion ¥641.5 billion Business lines Business lines Business lines Business lines Business lines Business lines Performance products, Pharmaceuticals and Plastic products and Chemical products, Healthcare and medical Industrial gases, related industrial materials, and others others resins, fibers, carbon fiber ICT, drug development equipment and facilities, others and composite materials, solutions, and and others water treatment systems next-generation and services, and others healthcare

Business domain Business domain Business domain Business domain Business domain Business domain Performance Products Health Care domain Performance Products Performance Products Health Care domain Industrial Materials domain domain domain domain Industrial Materials Industrial Materials domain domain Corporate Information

Group companies Group companies Group companies Group companies Group companies Group companies

*1 Listed company *2 MCHC Group total stake (%) *3 The three chemical operating companies will be integrated as the new-Mitsubishi Chemical Corporation on April 1, 2017.

Mitsubishi Chemical Holdings Corporation KAITEKI REPORT 2016 136 Corporate Information Major Subsidiaries and Affiliates (As of March 31, 2016)

Company Name Major Products or Lines of Business Capital Equity Number of Subsidiaries and Affiliates (Japan): Participation 343 (%) Number of Subsidiaries and Affiliates (Outside Japan): 406 Direct Investees

Mitsubishi Chemical Corporation Manufacture and marketing of chemical products ¥50.0 billion 100.0

Mitsubishi Tanabe Pharma Corporation Manufacture and marketing of pharmaceuticals ¥50.0 billion 56.3

Mitsubishi Plastics, Inc. Manufacture and marketing of polymer processing products ¥21.5 billion 100.0 Mitsubishi Chemical Holdings Europe GmbH Mitsubishi Chemical Holdings America, Inc. Mitsubishi Rayon Co., Ltd. Manufacture and marketing of chemical products ¥53.2 billion 100.0 Kasteler Strasse 45, 65203 Wiesbaden, Germany 655 Third Avenue, 15th Floor, Life Science Institute, Inc. Management of the healthcare solutions business ¥3.0 billion 100.0 TEL: [+49] (0)611-962-6923 New York, NY 10017, USA TEL: [+1] 212-672-9400 Taiyo Nippon Sanso Corporation Manufacture and marketing of industrial gases ¥37.3 billion 50.5 (14.0)

The KAITEKI Institute, Inc. Research and investigation into future societal trends ¥10 million 100.0

Indirect Investees Mitsubishi Chemical Holdings Corporation 1-1 Marunouchi 1-chome, Chiyoda-ku, Performance Products Domain Tokyo 100-8251, Japan TEL: [+81] (0)3-6748-7200 Electronics Applications Segment Verbatim Limited Marketing of recording media and computer peripheral equipment €3 million 100.0

Designed Materials Segment The Nippon Synthetic Chemical Industry Co., Ltd. Manufacture and marketing of polymer processing products ¥17.9 billion 50.9 Europe North Quadrant AG Management of subsidiaries that engage in the engineering plastic business CHF27 million 100.0 America 91 72 Industrial Materials Domain

Chemicals Segment Japan Kansai Coke and Chemicals Co., Ltd. Manufacture and marketing of coke ¥6.0 billion 51.0 343 Matheson Tri-Gas, Inc. Manufacture and marketing of industrial gases U.S.$42 100.0

Polymers Segment Asia Pacific Japan Polypropylene Corporation Manufacture and marketing of polypropylene ¥11.7 billion 65.0 232 Latin Japan Polyethylene Corporation Manufacture and marketing of polyethylene ¥7.5 billion 58.0 Africa America

Mitsubishi Rayon Lucite Group Limited Management of subsidiaries that engage in the MMA business £246 million 100.0 1 10

Health Care Domain

Health Care Segment API Corporation Manufacture and marketing of active pharmaceutical ingredients and intermediates ¥4.0 billion 100.0

LSI Medience Corporation Clinical testing and medical support services; marketing of in vitro diagnostic agents ¥3.0 billion 100.0 Mitsubishi Chemical Holdings (Beijing) Co., Ltd. Qualicaps Co., Ltd. Manufacture and marketing of capsules for pharmaceuticals and health food, and ¥2.8 billion 100.0 Room 710, Beijing Fortune Building, Dong San Huan Bei Lu 5, pharmaceutical processing equipment Chao Yang District, Beijing, 100004, PRC TEL: [+86] (0)10-6590-8621 Others

Mitsubishi Chemical Logistics Corporation Logistics and warehouse services ¥1.5 billion 100.0

Mitsubishi Chemical Engineering Corporation Engineering and construction services ¥1.4 billion 100.0

Disclaimer (Notes) 1. MCC operates businesses in the Performance Products and Industrial Materials domains and Others. This report contains forward-looking statements based on the Company’s current assumptions and beliefs in light of the information currently available to it, and are subject to risks and 2. MTPC operates businesses in the Health Care domain. uncertainties that may be beyond the Company’s control. Actual results could differ largely due to numerous factors, including but not limited to the following: Group companies execute 3. MPI operates businesses in the Performance Products domain. 4. MRC operates businesses in the Performance Products and Industrial Materials domains and Others. businesses in many different fields, such as information and electronics, polymers and processed products, pharmaceuticals, carbon and inorganic products, industrial gases and petrochemicals, 5. LSII operates businesses in the Health Care domain through its subsidiaries. and these businesses results are subject to influences of the global demands, exchange rates, price and procurement volume of crude oil and naphtha, trends in market price, speed of 6. TNSC operates businesses in the Industrial Materials domain. The equity participation ratio in parentheses ( ) for TNSC indicates the ratio owned by MCC. technological innovation, National Health Insurance price revisions, product liabilities, lawsuits, laws, and regulations. Product names, brand names, and service names used in this report are 7. The KAITEKI Institute conducts basic research activities that cannot be classified in any specific domain. denoted in italics and are trademarks or registered trademarks of the MCHC Group in Japan and/or overseas. Other product names, brand names, and service names may also be protected.

137 Mitsubishi Chemical Holdings Corporation KAITEKI REPORT 2016 Corporate Information Global Network (As of March 31, 2016) About Us

Corporate Brand Value Creation Process Company Name Major Products or Lines of Business Capital Equity Number of Subsidiaries and Affiliates (Japan): The Mitsubishi Chemical Holdings Group provides products and services based on Participation 343 (%) chemistry that contribute to the sustainable development for people, society and the Earth Number of Subsidiaries and Affiliates (Outside Japan): 406 in theDirect three Investees domains of Performance Products, Industrial Materials and Health Care. Mitsubishi Chemical Corporation Manufacture and marketing of chemical products ¥50.0 billion 100.0 KAITEKI is an original concept advocated by the MCHC Group that signifies “a sustainable condition which is Mitsubishi Tanabe Pharma Corporation Manufacture and marketing of pharmaceuticals ¥50.0 billion 56.3 comfortable for people, society and the Earth, transcending time and generations.” OrganizationalMitsubishi StructurePlastics, Inc. (As of March 31, 2016) Manufacture and marketing of polymer processing products ¥21.5 billion 100.0 The MCHC Group has decided to take the lead in acting on our vision for THE KAITEKI COMPANY aiming to realize KAITEKI. Mitsubishi Chemical Holdings Europe GmbH Mitsubishi Chemical Holdings America, Inc. Holding companyMitsubishi Rayon Co., Ltd. OperatingManufacture companies and marketing of chemical products ¥53.2 billion 100.0

Kasteler Strasse 45, 65203 Wiesbaden, Germany 655 Third Avenue, 15th Floor, Strategy MitsubishiLife Science Chemical Institute, Holdings Inc. •MitsubishiManagement Chemical of the healthcare Corporation solutions (MCC) business•Mitsubishi Tanabe Pharma Corporation¥3.0 billion (MTPC)100.0 TEL: [+49] (0)611-962-6923 New York, NY 10017, USA Corporation (MCHC) Mitsubishi Plastics, Inc. (MPI) Mitsubishi Rayon Co., Ltd. (MRC) TEL: [+1] 212-672-9400 Taiyo Nippon Sanso Corporation • Manufacture and marketing of industrial gases • ¥37.3 billion 50.5 (14.0) •Life Science Institute, Inc. (LSII) •Taiyo Nippon Sanso Corporation (TNSC) Contents The KAITEKI Institute, Inc. Research and investigation into future societal trends ¥10 million 100.0 Value Creation Process Results Governance Transition of Enhancing Corporate Value 3 Financial/Non-FinancialMitsubishi Highlights Chemical Holdings29 CorporationMessage from the Chairperson 63 NetIndirect sales Investees Operating income Toward Realizing KAITEKI 5 Financial Summary1-1 Marunouchi 1-chome, Chiyoda-ku,31 Directors 65 Performance Products Domain Expanding KAITEKI Value 9 Overview of BusinessTokyo 100-8251,Segments Japan 33 Corporate Governance 67 Summary OverviewTEL: [+81] of Business (0)3-6748-7200 Segments 33 Risk Management 71 Electronics Applications Segment Strategy Performance Products Domain 35 Compliance 73 Results Verbatim Limited Marketing of recording media and computer peripheral equipment billion billion €3 million 100.0 Message from the President 11 Industrial Materials Domain 41 ¥3,823.0 ¥280.0 Health Care Domain Financial Section 74 APTSIS 15 45 FYDesigned 2015 Materials Segment FY 2015 Fiscal 2013 to Fiscal 2015 Review 17 Innovation 49 The Nippon Synthetic Chemical Industry Co., Ltd. Manufacture and marketing of polymer processing products ¥17.9 billion 50.9 APTSIS 20 Sustainability 53 CorporateNorth Information Fiscal 2016 to Fiscal Europe2020 ¥2,Quadrant408.9 AG billion Management of subsidiaries¥1 that engage33 in.6 the engineeringbillion plastic business CHF27 million 100.0 New Medium-Term Management Plan CorporateAmerica Data 136 FY 2005 FY 2005 19 Dialog between the CFO91 and Investor 22 Major Subsidiaries 137 Global 72Network 138 Industrial Materials Domain Shareholder Value 27

NumberChemicals of Segment employees Number of outside directors/ Number of countries and regions Japan

total number of directors where the Group operates Governance Kansai Coke and Chemicals Co., Ltd. Manufacture and marketing of coke ¥6.0 billion 51.0 343 % Search Keyword 68,988Matheson Tri-Gas, Inc. Manufacture36 and marketing of industrial gases U.S.$42 100.0 (AsPolymers of March 31, Segment 2016) Of which, number of 22 Asia Pacific FY 2005 38FY 2015 Leadership Growth Strategies Results R&D personnel Japan Polypropylene Corporation Manufacture and marketing of polypropylene ¥11.7 billion 65.0 Message from the President 11 232 APTSIS 20 Shareholder Value Latin 27 5/14 Fiscal 2016 to Fiscal 2020 Japan Polyethylene Corporation Manufacture and marketing of polyethylene ¥7.5 billion 58.0 DialogAfrica between the CFO and Financial SectionAmerica 74 32,955 5,040 As of June 24, 2016 Investor 22 New Medium-Term (As of MarchMitsubishi 31, 2005) Rayon Lucite Group Limited Management Plan 10 Management of subsidiaries that engage in the MMA business £246 million 100.0 Message1 from the CTO 49 19 ESG (Environmental, Overview of Business Segments Of which, number of Message from the CSO 33 Social, Governance) Financial Section Health Care Domainpersonnel overseas (Chief Sustainability Officer) 53 Sustainability 53 Governance 63 Health Care SegmentApprox. 24,000 API Corporation Manufacture and marketing of active pharmaceutical ingredients and intermediates ¥4.0 billion 100.0

LSI Medience Corporation Clinical testing and medical support services; marketing of in vitro diagnostic agents ¥3.0 billion 100.0 Total number of products provided by the Group Number of patents held Mitsubishi Chemical Holdings (Beijing) Co., Ltd. Manufacture and marketing of capsules for pharmaceuticals and health food, and Qualicaps Co., Ltd. Number of awards in ¥2.8 billion 100.0 Room 710, Beijing Fortune Building, Dong San Huan Bei Lu 5, pharmaceutical processing equipment Chao Yang District, Beijing, 100004, PRC products and Japan Publication of the KAITEKI Report 2016 technologies category 13,176 TEL: [+86] (0)10-6590-8621 Others Positioning the realization of KAITEKI as its vision, International Integrated Reporting Council. medium-term targets of management indices are

Overseas Corporate Information FY 2015 9,352 the MCHC Group has promoted KAITEKI This report can be perused in conjunction with based on IFRS, however, the other figures are based Approx. 10 FY 2015 Mitsubishi20,000 Chemical Logistics Corporation Logistics and warehouse services ¥1.5 billion 100.0 Management through the pursuit of innovation while more detailed information available on MCHC’s on J-GAAP unless otherwise noted. working to improve both economic value and website. Mitsubishi Chemical Engineering Corporation Engineering and construction services ¥1.4 billion 100.0 sustainability. With a particular focus on our progress For detailed financial information, please refer to Period Covered by the Report Reduction of CO2 emissions Provision of water available Contribution to quality of Number of chemical product and outlook for corporate activities aimed at the our securities filings with the Financial Services Fiscal 2015 (April 2015–March 2016). Some through our products for domestic and industrial use life (QOL) improvement management seminar realization of KAITEKI , the MCHC Group publishes Agency. For detailed governance information, please information from fiscal 2016 is included. the KAITEKIDisclaimer Report. In addition to operating refer to our corporate governance report to the Tokyo participants summary, it includes items to be shared with our Stock Exchange. Reporting Boundary (Notes) 1. MCC operatesmillion businesses in the Performance Products andmillion Industrial Materials domains and Others. This report contains forward-looking statements based on the Company’s current assumptions and beliefs in light of the information currently available to it, and are subject to risks and stakeholders as well as what we judge to be highly MCHC has decided to adopt International This report covers information relating to MCHC and 2. MTPC operates businesses2 in the Health Care domain. uncertainties that may be beyond the Company’s control. Actual results could differ largely due to numerous factors, including but not limited to the following: Group companies execute 3. MPI operates t-CObusinesses in the Performance Products domain.tons % 1.43 550 194 pertinentbusinesses to our decision in many differentcriteria and fields, results such asof information and electronics,Financial Reporting polymers Standardsand processed (IFRS), products, effective pharmaceuticals, from carbonthe andMCHC inorganic Group. products, For matters industrial with gasesa different and petrochemicals, FY 20154. MRC operates businessesCO2 in the PerformanceFY 2015 Products and Industrial Materials domainsFY and 2015 Others. (compared materiality assessments for corporate activities. On the first quarter of fiscal 2016, the financial year reporting scope, we clearly specify the covered 5. LSII operates businesses in the Health Care domain through its subsidiaries. with FY 2009) 975 and these businesses results are subject to influences of the global demands, exchange rates, price and procurement volume of crude oil and naphtha, trends in market price, speed of 6. TNSC operates businesses in the Industrial Materials domain. The equity participation ratio in parentheses ( ) for TNSC indicates the ratio ownedFY by 2015 MCC. preparingtechnological this report, innovation, we referred National to the Health International Insurance price revisions,ending product March liabilities,31, 2017. lawsuits,In this report, laws, andforecasts regulations. of Product names,reporting brand scope. names, and service names used in this report are 7. The KAITEKI Institute conducts basic research activities that cannot be classified in any specific domain. Integrateddenoted Reporting in italics Framework and are trademarks promoted or byregistered the trademarksconsolidated of the MCHC results Group infor Japan fiscal and/or 2016 andoverseas. numerical Other product names, brand names, and service names may also be protected.

1 Mitsubishi Chemical Holdings Corporation KAITEKI REPORT 2016 Mitsubishi Chemical Holdings Corporation KAITEKI REPORT 2016 138